Recognition of betaine as an inhibitor of lipopolysaccharide- induced nitric oxide production in activated microglial cells

Iranian Biomedical Journal

Volumn 16, Issue 2, 2012, Pages 84-89

  Amiraslani, Banafsheh ^a,b   Sabouni, Farzaneh ^b   Abbasi, Shahsanam ^b   Nazem, Habiballah ^a   Sabet, Mohammadsadegh ^c  

^a PAYAME NOOR UNIVERSITY   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^c UNIVERSITY OF TABRIZ   (Iran)

Author keywords

Betaine; Lipopolysaccharides (LPS); Microglia; Nitric oxide (NO)

Indexed keywords

BETAINE; LIPOPOLYSACCHARIDE; NITRIC OXIDE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEWBORN; NONHUMAN; RAT;

ANIMALS; BETAINE; CELL SURVIVAL; CELLS, CULTURED; LIPOPOLYSACCHARIDES; LIPOTROPIC AGENTS; MICROGLIA; NEURODEGENERATIVE DISEASES; NITRIC OXIDE; RATS; RATS, WISTAR;

EID: 84865183912     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: 10.6091/IBJ.1012.2012     Document Type: Article

References (32)

1. He F, Sun YE. Glial cells more than support cells? Int J Biochem Cell Biol.2007;39(4):661-665.
2. Kim OS, Lee CS, Kim HY, Joe E-h, Jou I. Characterization of new microglia-like cells obtained from neonatal rat brain. Biochem Biophys Res Commun.2005;328(1):281-287.
3. Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR, et al. Role of microglia in central nervous system infections. Clin Microbiol Rev.2004 Oct;17(4):942-964.
4. Kreutzberg GW. Microglia, the first line of defense in brain pathologies. Arzneimittel-Forschung. 1995;45: 357-360.
5. Luo XG, Ding JQ, Chen SD. Microglia in the aging brain: relevance to neurodegeneration. Mol Neurodegener. 2010 Mar;5:12.
6. Stoecker K, Weigelt K, Ebert S, Karlstetter M, Walczak Y, Langmann T. Induction of STAP-1 promotes neurotoxic activation of microglia. Biochem Biophys Res Commun.2009;379(1): 121-126.
7. Jung HW, Mahesh R, Lee JG, Lee SH, Kim YS, Park YK. Pinoresinol from the fruits of Forsythia koreana inhibits inflammatory responses in LPS-activated microglia. Neurosci Lett. 2010 Aug;480(3):215-220.
8. Nakamichi K, Saiki M, Sawada M, Takayama-Ito M, Yamamuro Y, Morimoto K, et al. Rabies virus-induced activation of mitogen-activated protein kinase and NF-κB signaling pathways regulates expression of CXC and CC chemokine ligands in microglia. J Virol. 2005 Sep; 79(18):11801-11812.
9. Aloisi F. Immune function of microglia. Glia.2001 Nov;36(2): 165-179.
10. Ock J, Hong SH, Suk K. Identification of KT-15073 as an inhibitor of lipopolysaccharide-induced microglial activation. Biol Pharm Bull.2010;33(3):461-467.
11. Garden GA, Möller T. Microglia biology in health and disease. J Neuroimmune Pharmacol.2006 Jun; 1(2): 127-137.
12. Giulian D. Microglia and the immune pathology of Alzheimer disease. Am J Hum Genet. 1999 Jul;65(1):13-18.
13. Tilleux S, Berger J, Hermans E. Induction of astrogliosis by activated microglia is associated with a down-regulation of metabotropic glutamate receptor 5. J Neuroimmunol. 2007 Sep;189(1/2):23-30.
14. Flode AM, Combs CK. Mcroglia repetitively isolated from in vitro mixed glial cultures retain their initial phenotype. J Neurosci Methods.2007 Aug;164(2):218-224.
15. Glezer I, Simard AR, Rivest S. Neuroprotective role of the innate immune system by microglia. Neuroscience. 2007 Jul; 147(4):867-883.
16. Kaneko YS, Nakashima A, Mori K, Nagatsu T, Nagatsu I, Ota A. Lipopolysaccharide extends the lifespan of mouse primary-cultured microglia. Brain Res. 2009 Jul; 1279:9-20.
17. Nakamura T, Lipton SA. S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding. Cell Death and Differ.2007 Jul; 14(7): 1305-1314.
18. Moncada S, Bolaños JP. Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem.2006 Jun;97 (6): 1676-1689.
19. Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett.2006 May;580(13): 2994-3005.
20. Sachdev PS. Homocysteine and brain atrophy. Prog. Neuropsychopharmacol Biol Psychiatry. 2005 Sep;29 (7):1152-1161.
21. Craig SA. Betaine in human nutrition. Am J Clin Nutr.2004 Sep;80(3):539-549.
22. Go EK, Jung KJ, Kin JM, Lim H, Yu BP, Chung HY. Betaine modulates age-related NF-κB by thiol-enhancing action. Biol Pharm Bull. 2007 Dec;30 (12):2244-2249.
23. Giulian D, Baker TJ. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci. 1986 Aug; 6(8):2163-2178.
24. Harry GJ, Kraft AD. Neuroinflammation and microglia: Considerations and approaches for neurotoxicity assessment. Expert Opin Drug Metab Toxicol. 2008 Oct;4(10):1265-1277.
25. Neumann H, Kotter MR, Franklin RJM. Debris clearance by microglia: An essential link between degeneration and regeneration. Brain.2009;132(2):288-295.
26. van Rossum D, Hanisch UK. Microglia. Metab Brain Dis. 2004 Dec;19(3/4):393-411.
27. Gibbons HM, Dragunow M. Microglia induce neural cell death via a proximity-dependent mechanism involving nitric oxide. Brain Res.2006 Apr;1084(1):1-15.
28. Go EK, Jung KJ, Kim JY, Yu BP, Chung HY. Betaine suppresses proinflammatory signaling during aging: the involvement of nuclear factor-κB via nuclear factor-inducing kinase/lκB kinase and mitogen-activated protein kinases. J Gerontol A Biol Sci Med Sci. 2005 Oct;60(10):1252-1264.
29. Lin HC, Hsieh HM, Chen YH, Hu ML. S-Adenosylhomocysteine increases β-amyloid formation in BV-2 microglial cells by increased expressions of β-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters. Neuro Toxicol. 2009 Jul; 30(4):622-627.
30. Zhu XM, Ong WY. Changes in GABA Transporters in the rat hippocampus after kainate-induced neuronal injury: decrease in GAT-1 and GAT-3 but upregulation of betaine/GABA transporter BGT-1. J Neurosci Res. 2004 Aug; 77(3):402-409.
31. Schousboe A, Larsson OM, Sarup A, White HS. Role of the betaine/GABA transporter (BGT-1/GAT2) for the control of epilepsy. Eur J Pharmacol. 2004 Oct;500(1/3):281-287.
32. Olsen M, Sarup A, Larsson OM, Schousboe A. Effect of hyperosmotic conditions on the expression of the betaine-GABA-transporter (BGT-1) in cultured mouse astrocytes. Neurochem Res. 2005 Jun-Jul;30(6/7):855-865.